Diagnostic, prognostic, and predictive biomarkers in pancreatic cancer.
about
Systematic review of peri-operative prognostic biomarkers in pancreatic ductal adenocarcinomaPancreatic cancer surgery: past, present, and futureImproving pancreatic cancer diagnosis using circulating tumor cells: prospects for staging and single-cell analysisCan Molecular Biomarkers Change the Paradigm of Pancreatic Cancer Prognosis?Combining in Vitro Diagnostics with in Vivo Imaging for Earlier Detection of Pancreatic Ductal Adenocarcinoma: Challenges and Solutions.WT1-associated protein is a novel prognostic factor in pancreatic ductal adenocarcinoma.The Neutrophil/Lymphocyte Ratio at Diagnosis Is Significantly Associated with Survival in Metastatic Pancreatic Cancer Patients.Serum cytokine biomarker panels for discriminating pancreatic cancer from benign pancreatic disease.Metabolic profiling and novel plasma biomarkers for predicting survival in epithelial ovarian cancer.Intensity of follow-up after pancreatic cancer resectionPancreatic biomarkers: could they be the answer?Detecting circulating tumor material and digital pathology imaging during pancreatic cancer progression.The CA19-9 and Sialyl-TRA Antigens Define Separate Subpopulations of Pancreatic Cancer CellsPrognostic impact of hyaluronan and its regulators in pancreatic ductal adenocarcinoma.Quality-of-life (QoL) as a predictive biomarker in patients with advanced pancreatic cancer (APC) receiving chemotherapy: results from a prospective multicenter phase 2 trial.CXCL12-CXCR7 axis contributes to the invasive phenotype of pancreatic cancer.Diagnostic value of combining CA 19-9 and K-ras gene mutation in pancreatic carcinoma: a meta-analysis.Clinical next-generation sequencing successfully applied to fine-needle aspirations of pulmonary and pancreatic neoplasms.Insulin-like growth factor 1 receptor (IGF-1R) as a target of MiR-497 and plasma IGF-1R levels associated with TNM stage of pancreatic cancerExpression of c-fos was associated with clinicopathologic characteristics and prognosis in pancreatic cancerCross-species antibody microarray interrogation identifies a 3-protein panel of plasma biomarkers for early diagnosis of pancreas cancer.Role of intracellular and extracellular annexin A1 in migration and invasion of human pancreatic carcinoma cellsCombining clinicopathological predictors and molecular biomarkers in the oncogenic K-RAS/Ki67/HIF-1α pathway to predict survival in resectable pancreatic cancer.Urinary TIMP-1 and MMP-2 levels detect the presence of pancreatic malignancies.Overexpression of NDC80 is correlated with prognosis of pancreatic cancer and regulates cell proliferation.Prognosis Relevance of Serum Cytokines in Pancreatic Cancer.Application of a Serum Protein Signature for Pancreatic Cancer to Separate Cases from Controls in a Pancreatic Surveillance Cohort.Elevated GRP78 expression is associated with poor prognosis in patients with pancreatic cancerHLA-G impairs host immune response and predicts poor prognosis in pancreatic cancerMultimodality treatment of recurrent pancreatic cancer: Mith or reality?Pancreatic Cancer: a Challenge to CureNuclear translocation of fibroblast growth factor receptor 3 and its significance in pancreatic cancer.Heparanase regulates in vitro VEGF-C expression and its clinical significance to pancreatic ductal cell adenocarcinoma.Complexity of molecular alterations impacts pancreatic cancer prognosis.Identification of Poor-outcome Biliopancreatic Carcinoma Patients With Two-marker Signature Based on ATF6α and p-p38 "STARD Compliant".Targeting the insulin growth factor-1 receptor with fluorescent antibodies enables high resolution imaging of human pancreatic cancer in orthotopic mouse modelsPlasma microRNA panels to diagnose pancreatic cancer: Results from a multicenter studyGold Nanoparticles for In Vitro Diagnostics.The role of quantitative mass spectrometry in the discovery of pancreatic cancer biomarkers for translational science.Potential epigenetic biomarkers for the diagnosis and prognosis of pancreatic ductal adenocarcinomas.
P2860
Q26739910-34395D51-7FF6-4810-8677-66AE8420A163Q26781555-90FFFF19-D26A-43E9-B64A-E9C5D3934C33Q26782719-8CFBFFFA-282E-4653-8F30-EC121DB7130FQ28066454-557644DC-9560-44DF-AEF4-A3F26CED2DBFQ30368922-0E995505-1397-48E0-9859-5ECA29820715Q33598160-75CB6612-67A0-4CCF-AEE4-5E79EA2F602DQ33624392-4E73FEE8-A7C4-4480-B705-8AF0E8E0E9F7Q33655712-EE1251CC-C0CA-40E9-84AD-D3B499A9AE5AQ33762042-FC63EACD-FF37-43B6-A2A1-03B11ED5BFB2Q33791048-148DFD89-78A5-4E2D-941A-E6F65A106D53Q33801371-57912C8F-18DE-4E1B-B0DD-776EB1F58B45Q33803923-C5E3162C-AECE-4521-B4EE-ADA2078E92FDQ33826323-BB4185BB-BD85-4A87-8FC8-AEF0CF4BA5A1Q34385867-844E23CA-735F-492B-91EF-F1AAC2ABF5A1Q34484260-52A7FD5C-5BC4-4F6D-AECC-3BC6642655FCQ34537885-D6116FD0-18CD-4B50-AE05-9A9432EB05CBQ34547888-BE632172-B06B-4144-91D8-C52FC9BAFD2AQ34871953-FB064CEC-02A8-4DBB-93E1-7CFA060A7CE1Q35131201-9E4723F2-3399-47CC-BD29-1FD6E46B920EQ35196594-8E2B5CDD-C0C2-4F72-A724-42EB41DCC138Q35343764-81881F0B-CEA6-4AB5-BB94-472041DEF1A4Q35522087-711D70EB-8B8F-4C1F-9F88-F3F5290D02B6Q35677885-EE1E0E1F-5458-4705-9EFB-F291ED0CA8F8Q35678051-9E0E29C0-0E05-45DB-9A18-7B53B6950BC5Q35835237-89C33D2E-389A-4394-AC66-929E57910FD7Q35963911-D228B3FE-FFB5-47F5-A32D-35F582ECF30CQ36042474-28D23FE6-D362-4D7E-99A3-259A3AA2F661Q36245668-5D783A16-0CEB-4C02-B2AE-4250901C7F66Q36309539-2ED4EE88-FDFC-4EF5-B9AB-7A2A19F8A0DEQ36369834-28941563-1192-4961-924A-86439732E7F4Q36400081-D01AF214-67F9-4BCB-BA45-2A005A5A321EQ36464545-8B5625E4-15FE-418E-A9C1-9761B461BF4AQ36524769-0DC4C132-A699-4A2F-9279-D2D12B95A061Q36563027-DD099A4F-0F82-4D29-9BFA-34D19E1D8D0FQ37016687-33A41C41-86A7-4143-99AF-2FACB22E8442Q37109728-98474B07-CC3F-4976-BAF4-8594FA9D2C30Q37520294-1E637F85-E5B4-485B-8847-A0D1A1DE0FCAQ37580069-086A3613-2AB5-42E5-94BF-FC04B5C541EAQ37720601-E7F9298B-E3F3-4BEA-926B-52E0FA634100Q38115619-4A0F376D-062F-4B28-9148-07993C0328C7
P2860
Diagnostic, prognostic, and predictive biomarkers in pancreatic cancer.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Diagnostic, prognostic, and predictive biomarkers in pancreatic cancer.
@en
type
label
Diagnostic, prognostic, and predictive biomarkers in pancreatic cancer.
@en
prefLabel
Diagnostic, prognostic, and predictive biomarkers in pancreatic cancer.
@en
P2093
P2860
P356
P1476
Diagnostic, prognostic, and predictive biomarkers in pancreatic cancer.
@en
P2093
Charles J Yeo
Jonathan R Brody
Jordan M Winter
P2860
P356
10.1002/JSO.23192
P577
2012-06-21T00:00:00Z